Cargando…

Drug-eluting beads in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Abe, Hiroyuki, Kamimura, Kenya, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305019/ https://www.ncbi.nlm.nih.gov/pubmed/28246550 http://dx.doi.org/10.1177/1756283X16681710

Ejemplares similares

Drug eluting beads on cytology smears
por: Manglik, Niti, et al.
Publicado: (2012)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
por: Ikeda, Masafumi, et al.
Publicado: (2022)

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016)

Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma
por: Dasse, Kathy Diener, et al.
Publicado: (2016)

Rare complication of hepatocellular carcinoma in Wilson's disease
por: Ohkoshi‐Yamada, Marina, et al.
Publicado: (2021)

Advances in the treatment of hepatocellular carcinoma using drug-eluting beads
por: Wei, Guangxu, et al.
Publicado: (2020)

Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
por: Song, Jeong Eun, et al.
Publicado: (2017)

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma
por: Imai, Yusuke, et al.
Publicado: (2016)

Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization
por: Fujita, Masashi, et al.
Publicado: (2019)

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
por: Abe, Hiroyuki, et al.
Publicado: (2023)

Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
por: Greco, Giorgio, et al.
Publicado: (2017)

Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
por: Facciorusso, Antonio
Publicado: (2018)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
por: Kamimura, Kenya, et al.
Publicado: (2019)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2020)

Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2014)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
por: Woo, Hyun Young, et al.
Publicado: (2015)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
por: Toro, Adriana, et al.
Publicado: (2015)

Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
por: Zhou, Guan-Hui, et al.
Publicado: (2018)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma
por: Arabi, Mohammad, et al.
Publicado: (2015)

Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Kim, Young Woon, et al.
Publicado: (2018)

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
por: Wang, Tian-Cheng, et al.
Publicado: (2020)

Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Li, Jinpeng, et al.
Publicado: (2021)

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)
por: Liu, Yi-Sheng, et al.
Publicado: (2022)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Shao, Guoliang, et al.
Publicado: (2022)

Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature
por: Shibata, Osamu, et al.
Publicado: (2020)

Advances in the Treatment of Gastrointestinal Bleeding: Safety and Efficiency of Transnasal Endoscopy
por: Abe, Hiroyuki, et al.
Publicado: (2021)

Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature
por: Morita, Shinichi, et al.
Publicado: (2019)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
por: Chang, Wei-Chou, et al.
Publicado: (2021)

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)

Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment
por: Boatta, Emanuele, et al.
Publicado: (2013)

Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma: Erratum
Publicado: (2015)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
por: Zhang, Zi-shu, et al.
Publicado: (2019)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma—A pilot study
por: Lahti, Steven, et al.
Publicado: (2017)

Selective doxorubicin drug eluting beads chemoembolization of hypovascular hepatocellular carcinoma using cone beam computed tomography
por: Kalra, Naveen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_llqe1ftamionlfeurhtqm6kh89